|4May 17, 4:42 PM ET

Berlin Alejandro M. 4

4 · VACCINEX, INC. · Filed May 17, 2019

Insider Transaction Report

Form 4
Period: 2019-05-15
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-05-15+7,7187,718 total
    Exercise: $7.78From: 2020-05-15Common Stock (7,718 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $13.60Exp: 2027-09-15Common Stock (6,396 underlying)
    6,396
Footnotes (2)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT